Moderna
Biotech

FDA accepts filing for Moderna flu vaccine after swift rethink

The FDA has accepted Moderna’s revised influenza vaccine filing, putting the biotech on track to win approval before the 2026-27 flu season.
Nick Paul Taylor Feb 18, 2026 9:21am
Two businessmen pushing giant puzzle pieces together as the sun sets behind them

Novartis finds natural partnership in macrocycle biotech

Feb 18, 2026 10:13am
Blue snowshoes stuck in the snow in front of a forest

Korsana crosses into crowded Alzheimer's field with $175M

Feb 18, 2026 6:00am
Eli Lilly Lilly

Lilly pays CSL $100M for IL-6 drug that flunked transplant study

Feb 18, 2026 5:07am
Bill Cassidy and RFK Jr
Favicon Fierce Pharma

Sen. Cassidy offers proposals to reshape FDA

Feb 18, 2026 11:45am
Healthy foods surrounding chalk drawing of gut

Rasayana Tx ingests GI candidate in $36M deal

Feb 18, 2026 10:40am
More News

Sensei steps back from brink by finding Faeth merger

Feb 18, 2026 10:33am

Fierce Biotech Fundraising Tracker '26: Korsana, ILiAD & more

Feb 18, 2026 9:30am

Preclinical eye disease biotech sets sights on $17M NYSE IPO

Feb 18, 2026 8:55am

RoukenBio, AVS Bio partner for predictable antibody development

Feb 17, 2026 3:45pm